ArticleTurkish journal of medical sciences2026
HLA allele and haplotype diversity in Central Anatolia: a comparative analysis of donors and transplant candidates across six HLA loci (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA-DPB1).
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Human leukocyte antigen (HLA) polymorphisms play a central role in immune recognition, disease susceptibility, and transplant success. The distribution of HLA alleles and haplotypes varies among ethnic and geographic populations. Despite several regional studies conducted in Türkiye, large-scale and comprehensive investigations comparing HLA profiles between healthy individuals and transplant candidates remain limited. The aim of this study was to compare the distribution of HLA profiles among donors, hematopoietic stem cell transplantation (HSCT) candidates, and solid organ transplant candidates. Materials and methods: A total of 8472 individuals were included in the study, comprising 6422 donors and 2050 transplant candidates. HLA genotyping was performed using polymerase chain reaction with sequence-specific primers and polymerase chain reaction with sequence-specific oligonucleotide probes. Allele, genotype, and haplotype frequencies were calculated using the PyPop (version 1.2.0) and GENE[RATE] software tools. Results: The most frequent alleles at the HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA-DPB1 loci were similar across all groups, with A*02, B*35, C*07, DRB1*11, DQB1*03, and DPB1*04 observed as the predominant alleles. Several alleles were significantly overrepresented in solid organ transplant candidates compared with donors, including A*31, A*33, B*15, B*42, B*51, B*54, DRB1*04, and DRB1*12, whereas DRB1*11 was significantly underrepresented (p < 0.05). A*23 was also observed at a significantly higher frequency in kidney transplant candidates. No significant allele differences were observed between HSCT candidates and donors. Haplotype analysis revealed that the most prevalent six-locus haplotype (A:B:C:DRB1:DQB1:DPB1) was 02~35~04~11~03~04 in donors, whereas 24~35~04~11~03~04 was observed in HSCT candidates and 24~35~04~04~03~04 in solid organ transplant candidates. Conclusion: To our knowledge, this study represents the largest and most comprehensive analysis of HLA distribution in Türkiye to date and the first to report six-locus HLA haplotypes, including the HLA-DPB1 locus, in transplant candidates. The results indicate that solid organ transplant candidates exhibit significant differences in HLA allele and haplotype frequencies compared with healthy donors. These findings underscore the importance of region-specific HLA data in optimizing donor selection and potentially improving transplant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.